{"id":"W2123526148","doi":"10.1016/s0140-6736(10)61389-x","title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3284,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cabazitaxel; Mitoxantrone; Docetaxel; Medicine; Prostate cancer; Prednisone; Internal medicine; Oncology; Taxane; Enzalutamide; Clinical endpoint; Abiraterone acetate; Hazard ratio; Randomized controlled trial; Cancer; Surgery; Chemotherapy; Androgen deprivation therapy; Confidence interval; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001908785,0.002792217,0.004622997,0.000785846,0.0006614128,0.001610505,0.001276245,0.002811145,0.01054617],"category_scores_gemma":[0.001733507,0.001147043,0.003223353,0.0008770069,0.002428998,0.001687382,0.00060116,0.004440531,0.001715099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001343139,"about_ca_system_score_gemma":0.001466274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003088439,"about_ca_topic_score_gemma":0.005591539,"domain_scores_codex":[0.9990195,0.0004850037,0.00005512375,0.0001956871,0.00005805562,0.0001866535],"domain_scores_gemma":[0.9988362,0.0003825893,0.000206191,0.0001131296,0.00005140959,0.0004104398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9886187,0.002433168,0.0001611117,0.0004292121,0.0005248468,0.0000323705,0.00003088667,0.0002302438,0.0008209422,0.00006043056,0.0003104556,0.006347683],"study_design_scores_gemma":[0.9611387,0.03739816,0.0005436244,0.00002439671,0.000310838,0.00001694386,0.00001389766,0.0001214268,0.00009855493,0.00007040784,0.0002518299,0.00001117863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977928,0.01055313,0.0007790205,0.00109122,0.001577454,0.003599167,0.001647951,0.0001622047,0.002661929],"genre_scores_gemma":[0.9809652,0.006526393,0.00106145,0.000957203,0.0009925042,0.002531478,0.001205965,0.00003443399,0.005725423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01054617,"threshold_uncertainty_score":0.03528047,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1328304745619498,"score_gpt":0.4254878231418871,"score_spread":0.2926573485799373,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}